| Old drugs, new uses: Drug repurposing in hematological malignancies VP Kale, H Habib, R Chitren, M Patel, KC Pramanik, SC Jonnalagadda, ... Seminars in cancer biology 68, 242-248, 2021 | 52 | 2021 |
| Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents SS Dinavahi, R Gowda, CG Bazewicz, MB Battu, JM Lin, RJ Chitren, ... European journal of medicinal chemistry 187, 111962, 2020 | 36 | 2020 |
| Mcl-1 inhibition: managing malignancy in multiple myeloma OS Al-Odat, M von Suskil, RJ Chitren, WO Elbezanti, SK Srivastava, ... Frontiers in pharmacology 12, 699629, 2021 | 33 | 2021 |
| Bruton’s tyrosine kinase targeting in multiple myeloma M Von Suskil, KN Sultana, WO Elbezanti, OS Al-Odat, R Chitren, ... International journal of molecular sciences 22 (11), 5707, 2021 | 19 | 2021 |
| Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents LN Solano, GL Nelson, CT Ronayne, S Jonnalagadda, SK Jonnalagadda, ... Scientific reports 10 (1), 17969, 2020 | 19 | 2020 |
| Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like … WO Elbezanti, OS Al-Odat, R Chitren, JK Singh, SK Srivastava, K Gowda, ... Frontiers in Pharmacology 13, 894535, 2022 | 11 | 2022 |
| Cancer on fire: role of inflammation in prevention and treatment MK Pandey, M Von Suskil, R Chitren, O Al-Odat, SC Jonnalagadda, ... Current advances for development of functional foods modulating inflammation …, 2022 | 6 | 2022 |
| Drug Resistance Can be Overcome in Multiple Myeloma and Acute Myeloid Leukemia By Targeting Mcl-1 with the Small Chemical KS18 OS Al-Odat, R Chitren, M Von Suskil, O Aloudat, K Gowda, ... Blood 142 (Supplement 1), 5771-5771, 2023 | 1 | 2023 |
| Investigating the Therapeutic Potential of Soursop in Treating Hematologic Malignancies SM Paparo, R Mendoza, R Chitren, O Al-Odat, E Nelson, S Jonnalagadda, ... | | 2024 |
